Differential distribution of microRNAs in breast cancer grouped by clinicopathological subtypes

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 3197-3203

  Li, Jian Yi ^a   Jia, Shi ^a   Zhang, Wen Hai ^a   Zhang, Yang ^a   Kang, Ye ^a   Li, Pi Song ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Clinicopathological subtype; Heterogeneity; MicroRNA

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MICRORNA; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; CLASSIFICATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KI-67 ANTIGEN; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 84880379431     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.3197     Document Type: Article

References (19)

1. Aihara M, Wheeler TM, Ohori M, et al (1994) Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology, 43, 60-6
2. Balsat C, Blacher S, Signolle N, et al (2011) Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description. ISRN Obstet Gynecol, 25, 1-7.
3. Caporali A, Emanueli C (2011). MicroRNA regulation in angiogenesis. Vascul Pharmacol, 55, 79-86.
4. Cheng C, Fu X, Alves P, et al (2009). mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol, 10, R90.
5. Choudhry H, Catto JW (2011). Epigenetic regulation of microRNA expression in cancer. Methods Mol Biol, 676, 165-84.
6. Cortés-Sempere M, Ibáñez de Cáceres I (2011). microRNAs as novel epigenetic biomarkers for human cancer. Clin Transl Oncol, 13, 357-62
7. Goldhirsch A, Wood WC, Coates AS, et al (2011) Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol, 22, 1736-47.
8. Hughes DP (2009). How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res, 152, 479-96
9. Iorio MV, Ferracin M, Liu CG, et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70
10. Juan HF, Huang HC (2007) Bioinformatics: microarray data clustering and functional classification. Methods Mol Biol, 382, 405-16.
11. Kitadai Y, Ellis LM, Takahashi Y, et al (1995). Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin Cancer Res, 1, 1095-102.
12. Kreiner T, Buck KT (2005). Moving toward whole-genome analysis: a technology perspective. Am J Health Syst Pharm, 62, 296-305.
13. Krishna MC, Matsumoto S, Yasui H, et al (2012). Electron paramagnetic resonance imaging of tumor pO2. Radiat Res, 177, 376-86
14. Li JY, Zhang Y, Zhang WH, et al (2012) Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers. Asian Pac J Cancer Prev, 13, 1901-6.
15. Orlando PA, Gatenby RA, Brown JS (2013). Tumor evolution in space: the effects of competition colonization tradeoffs on tumor invasion dynamics. Front Oncol, 3, 45.
16. Pritchard CC, Cheng HH, Tewari M (2012). MicroRNA profiling: approaches and considerations. Nat Rev Genet, 13, 358-69.
17. Stransky B, de Souza SJ (2012). Modeling tumor evolutionary dynamics. Front Physiol, 3, 480.
18. Teixeira MR, Heim S (2011). Cytogenetic analysis of tumor clonality. Adv Cancer Res, 112, 127-49
19. Wilson DF, Cerniglia GJ (1992) Localization of tumors and evaluation of their state of oxygenation by phosphorescence imaging. Cancer Res, 52, 3988-93.